CS175500B2 - - Google Patents

Info

Publication number
CS175500B2
CS175500B2 CS215A CS21576A CS175500B2 CS 175500 B2 CS175500 B2 CS 175500B2 CS 215 A CS215 A CS 215A CS 21576 A CS21576 A CS 21576A CS 175500 B2 CS175500 B2 CS 175500B2
Authority
CS
Czechoslovakia
Application number
CS215A
Other languages
Czech (cs)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CS175500B2 publication Critical patent/CS175500B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
CS215A 1974-08-05 1975-07-22 CS175500B2 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2438020A DE2438020A1 (de) 1974-08-05 1974-08-05 18-methyl-19-nor-20-keto-pregnane und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
CS175500B2 true CS175500B2 (en:Method) 1977-05-31

Family

ID=5922668

Family Applications (2)

Application Number Title Priority Date Filing Date
CS5170A CS175498B2 (en:Method) 1974-08-05 1975-07-22
CS215A CS175500B2 (en:Method) 1974-08-05 1975-07-22

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CS5170A CS175498B2 (en:Method) 1974-08-05 1975-07-22

Country Status (17)

Country Link
US (1) US4029777A (en:Method)
JP (1) JPS5141347A (en:Method)
AT (1) AT345998B (en:Method)
BE (1) BE832124A (en:Method)
CA (1) CA1037027A (en:Method)
CH (1) CH611910A5 (en:Method)
CS (2) CS175498B2 (en:Method)
DD (1) DD120192A5 (en:Method)
DE (1) DE2438020A1 (en:Method)
DK (1) DK136369C (en:Method)
ES (1) ES439720A1 (en:Method)
FR (1) FR2281123A1 (en:Method)
GB (1) GB1512258A (en:Method)
HU (1) HU171684B (en:Method)
IL (1) IL47770A (en:Method)
NL (1) NL7509326A (en:Method)
SE (1) SE404804B (en:Method)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61144199A (ja) * 1984-12-18 1986-07-01 Pioneer Electronic Corp スピ−カ用紙製振動部材の製造方法
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
EP0382790A4 (en) * 1987-08-25 1991-03-27 Kelvin W. Gee Compositions and methods for alleviating stress, anxiety and seizure activity
US5175154A (en) * 1987-11-25 1992-12-29 Research Corporation Technologies, Inc. 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds
PL3498725T3 (pl) 2013-04-17 2021-11-08 Sage Therapeutics, Inc. 19-Nor C3,3-dipodstawiony C21-N-pirazolilo-steroid do zastosowania w terapii
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
LT2986624T (lt) 2013-04-17 2020-07-10 Sage Therapeutics, Inc. Neuroaktyvūs 9-nor steroidai, skirti gydymo metodams
US20160068563A1 (en) 2013-04-17 2016-03-10 Boyd L. Harrison 19-nor neuroactive steroids and methods of use thereof
RS61733B1 (sr) 2013-07-19 2021-05-31 Sage Therapeutics Inc Neuroaktivni steroidi, njihove kompozicije i upotrebe
WO2015027227A1 (en) 2013-08-23 2015-02-26 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
CN117024502A (zh) 2014-10-16 2023-11-10 萨奇治疗股份有限公司 靶向cns障碍的组合物和方法
RS60642B1 (sr) 2014-10-16 2020-09-30 Sage Therapeutics Inc Kompozicije i postupci za lečenje poremećaja cns-a
JP6893173B2 (ja) 2014-11-27 2021-06-23 セージ セラピューティクス, インコーポレイテッド Cns障害を処置するための組成物および方法
PT3250210T (pt) 2015-01-26 2021-03-26 Sage Therapeutics Inc Composições e métodos para o tratamento de distúrbios do snc
DK3258939T3 (da) 2015-02-20 2022-12-12 Sage Therapeutics Inc Neuroaktive steroider, sammensætninger og anvendelser heraf
MA45599A (fr) 2016-07-11 2019-05-15 Sage Therapeutics Inc Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
JP7065825B2 (ja) 2016-07-11 2022-05-12 セージ セラピューティクス, インコーポレイテッド C7、c12、およびc16置換神経刺激性ステロイドおよびそれらの使用方法
BR112020012712A8 (pt) * 2017-12-22 2022-03-03 Sage Therapeutics Inc Composto ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica e usos do referido composto para o tratamento de distúrbios do snc
WO2020243488A1 (en) 2019-05-31 2020-12-03 Sage Therapeutics, Inc. Neuroactive steroids and compositions thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1409239A (en) * 1971-11-11 1975-10-08 Glaxo Lab Ltd Process for the preparation of 3alpha-hydroxy-5alpha-steroids
BE791196A (fr) * 1971-11-11 1973-05-10 Glaxo Lab Ltd Nouveaux steroides, leur procede de preparation et leurs applications

Also Published As

Publication number Publication date
US4029777A (en) 1977-06-14
SE404804B (sv) 1978-10-30
CH611910A5 (en:Method) 1979-06-29
DK344475A (da) 1976-02-06
DE2438020A1 (de) 1976-02-26
IL47770A0 (en) 1975-10-15
BE832124A (fr) 1976-02-05
AT345998B (de) 1978-10-10
CS175498B2 (en:Method) 1977-05-31
DD120192A5 (en:Method) 1976-06-05
ES439720A1 (es) 1977-03-01
AU8351575A (en) 1977-02-03
HU171684B (hu) 1978-02-28
DK136369B (da) 1977-10-03
FR2281123A1 (fr) 1976-03-05
CA1037027A (en) 1978-08-22
NL7509326A (nl) 1976-02-09
DK136369C (da) 1978-02-27
SE7508777L (sv) 1976-02-06
GB1512258A (en) 1978-05-24
JPS5141347A (en) 1976-04-07
ATA600475A (de) 1978-02-15
IL47770A (en) 1978-10-31

Similar Documents

Publication Publication Date Title
FI750114A7 (en:Method)
DK675374A (en:Method)
CS175498B2 (en:Method)
FR2257123B1 (en:Method)
DK66875A (en:Method)
FI750676A7 (en:Method)
FR2258479B1 (en:Method)
FR2293809B3 (en:Method)
AU495920B2 (en:Method)
CS170675B1 (en:Method)
CS171504B1 (en:Method)
CH578340A5 (en:Method)
CH590720A5 (en:Method)
CH575705A5 (en:Method)
CH575612B5 (en:Method)
CH575110A5 (en:Method)
CH586602A5 (en:Method)
CH572577A5 (en:Method)
CH570819A5 (en:Method)
CH569468A5 (en:Method)
CH208274A4 (en:Method)
BG21707A1 (en:Method)
CH593253A5 (en:Method)
CH587174A4 (en:Method)
CH592522A5 (en:Method)